Clinical Characteristics of Interstitial pneumonia with autoimmune features: A Single-Center Experience

Abstract

Objective: Interstitial pneumonia with autoimmune features (IPAF) is a recently determined condition characterized by clinical or serological symptoms indicative of an underlying autoimmune process but without fulfilling connective tissue disease classification criteria. This study aims to identify the clinical, serological, and morphological features of AFIP patients. Materials and Methods: This is a retrospective cohort study. A total of 38 patients diagnosed with AFIP in the Rheumatology outpatient clinic of XXX University between 2015 and 2022 were included in the study. Results: The patients' mean age was 58.26 ±12.31. The majority of patients (n=27, 71% female) were female. The most frequently described clinical features among patients were inflammatory arthritis or polyarticular morning joint stiffness lasting more than 60 minutes (n=9, 23.6%) and Raynaud's phenomenon (n=9, 23.6%). The most commonly identified serological findings were antinuclear antibody (ANA) (n=27, 71.1%), Anti-Ro/SSA antibody (n=6, 15.8%), rheumatoid factor (n=5, 13.2%), and Anti-cyclic citrullinated peptide (Anti-CCP) (n=5, 13.2%) positivity. The mean follow-up was 43.21 ± 23.30 months, and only one out of 10 patients who died during the follow-up was associated with IPAF. Thirty-one (81.5%) patients were treated with immunosuppressants, and 29 (76.3%) were given steroid treatment. The most commonly used immunosuppressive drug with steroids was cyclophosphamide (n=9, 23.6%). Anti-fibrotic therapy was administered to 4 patients (10.5%) who did not respond adequately to immunosuppressive drugs. Morphologically, the most frequent radiological pattern was the non-specific interstitial pneumonia (NSIP) pattern (n=12, 26.3%). Conclusion: This single-center study demonstrated that IPAF primarily affects females, often presents with joint manifestations and Raynaud's phenomenon, and more frequently exhibits the NSIP pattern on imaging. Due to the heterogeneity of IPAF, defining its clinical and morphological characteristics is essential for early diagnosis and treatment.

Keywords

• Rheumatic disease
• interstitial lung disease
• interstitial pneumonia with autoimmune features
• idiopathic pulmonary fibrosis

Otoimmün Özellikler Gösteren İnterstisyel Pnömoninin Klinik Özellikleri: Tek Merkez Deneyimi

Abstract

Giriş ve Amaç: Otoimmün özellikli interstisyel pnömoni (OÖİP), altta yatan otoimmün bir süreci düşündüren klinik veya serolojik özelliklerin mevcut olduğu; ancak bağ doku hastalıkları için tanımlanmış sınıflandırma kriterlerinin karşılanmadığı, yakın zamanda tanımlanmış bir antitedir. Bu çalışmanın amacı, OÖİP hastalarının klinik, serolojik ve morfolojik özelliklerini belirlemektir. Gereç ve Yöntemler: Bu çalışma bir retrospektif kohort çalışmasıdır. Çalışmaya 2015-2022 tarihleri arasında XXX üniversitesi Romatoloji bölümünde OÖİP tanısı ile takip edilen 38 hasta dahil edilmiştir. Bulgular: Çalışmadaki hastaların yaş ortalamaları 58,26 ± 12,31 idi. Çoğunluğu (n=27, %71) kadın hastalar oluşturmaktaydı. Hastalarda en sık tanımlanan klinik özellikler inflamatuar artrit veya 60 dakikadan uzun süren poliartiküler sabah sertliği (n=9, %23,6) ve Raynaud fenomeniydi (n=9, %23,6). En sık tanımlanan serolojik bulgular antinükleer antikor (ANA) pozitifliği (n=27, %71,1), Anti-Ro/SSA antikor pozitifliği (n=6, %15,8), romatoid faktör (RF) (n=5, %13,2) ve Anti-Siklik sitrüline peptid pozitifliği (Anti-CCP) (n=5, %13,2) idi. Ortalama takip süresi 43,21 ± 23,30 ay olup, takip süresince ex olan 10 hastadan yalnızca biri OÖIP ile ilişkilendirilmiştir. Hastaların 31’i (%81,5) immünsüpresiflerle tedavi edilmiş olup, 29’una (%76,3) steroid tedavisi verilmiştir. Steroidlerle birlikte en çok kullanılan immünsüpresif ilaç siklofosfamid (n=9, %23,6) idi. İmmünsupresif ilaçlara yeterli yanıt alınamayan 4 hastaya (%10,5) ise anti-fibrotik verilmiştir. Morfolojik alanda radyolojik paternler içerisinde en sık nonspesifik interstisyel pnömoni (NSİP) paterni gözlenmiştir (n= 15, %39,5). Sonuç: Tek merkez deneyimini sunan bu çalışmada OÖİP’nin çoğunlukla kadın hastalardan oluştuğu, sıklıkla eklem bulguları ve Raynaud ile prezente olduğu ve görüntülemede en sık NSİP paterni özelliklerini gösterdikleri belirlenmiştir. Oldukça heterojen özellikler gösteren OÖİP’nin klinik ve morfolojik özelliklerinin iyi belirlenmesi, hastalığın erken tanısı ve tedavisi için önemlidir.

Keywords

• otoimmün özellikli interstisyel pnömoni
• Romatolojik hastalık
• interstisyel akciğer hastalığı
• idiopatik pulmoner fibrozis

Supporting Institution

YOK

Thanks

YOK

References

1. 1 Travis, WD, Costabel, U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al., ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, American journal of respiratory and critical care medicine, 2013, 188, 733-748.
2. 2 Fischer, A, Antoniou, KM, Brown, KK, Cadranel, J, Corte, TJ, du Bois, RM, et al., “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features, The European respiratory journal, 2015, 46, 976-987.
3. 3 Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, et al., Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?, American journal of respiratory and critical care medicine, 2007, 176, 691-697.
4. 4 Fischer, A, West, SG, Swigris, JJ, Brown, KK, du Bois, RM. Connective tissue disease-associated interstitial lung disease: a call for clarification, Chest, 2010, 138, 251-256.
5. 5 Vij, R, Noth, I, Strek, ME, Autoimmune-featured interstitial lung disease: a distinct entity, Chest, 2011, 140, 1292-1299.
6. 6 Travis, WD, Hunninghake, G, King, TE Jr, Lynch, DA, Colby, TV, Galvin, JR, et al., Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society Project, American journal of respiratory and critical care medicine, 2008, 177, 1338-1347.
7. 7 Oldham, JM, Adegunsoye, A, Valenzi, E, Lee, C, Witt, L, Chen, L, et al., Characterisation of patients with interstitial pneumonia with autoimmune features, The European respiratory journal, 2016, 47, 1767-1775.
8. 8 Kim, HC, Lee, JH, Chae, EJ, Song, JS, Song, JW, Long-term clinical course and outcome of interstitial pneumonia with autoimmune features, Respirology, 2020, 25, 636-643.

9. 9 Chartrand, S, Swigris, JJ, Stanchev, L, Lee, JS, Brown, KK, Fischer, A, Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience, Respiratory medicine, 2016, 119, 150-154.
10. 10 Sambataro, G, Sambataro, D, Torrisi, SE, Vancheri, A, Colaci, M, Pavone, M, et al., Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients, Respiratory medicine, 2019, 150, 154-160.
11. 11 11. Sebastiani, M, Cassone, G, De Pasquale, L, Cerri, S, Della Casa, G, Vacchi, C, et al., Interstitial pneumonia with autoimmune features: A single center prospective follow-up study, Autoimmunity reviews, 2020, 19, 102451